Showing 19,941 - 19,960 results of 36,050 for search '(( significant decrease decrease ) OR ( significant ((level increased) OR (greatest decrease)) ))', query time: 0.63s Refine Results
  1. 19941
  2. 19942

    Sketches of the two circuits used. by Lars-Olav Harnisch (22008639)

    Published 2025
    “…In the design of circuit-2, MP exceeded the 12 J/min threshold in both lung simulators at elevated RR and could only be decreased through valve closure followed by a consequential hypoventilation in one simulator.…”
  3. 19943

    Key Resources. by Jeffrey Chin (22538086)

    Published 2025
    “…These experiments revealed that Tax1bp1 protein abundance does not significantly change early after infection in AMs but does in BMDMs; moreover, early after infection, Tax1bp1-deficiency reduced necrotic-like cell death -- an outcome that favors <i>Mtb</i> replication -- in AMs but not BMDMs. …”
  4. 19944

    Tax1bp1-deficiency reduces autophagy flux. by Jeffrey Chin (22538086)

    Published 2025
    “…These experiments revealed that Tax1bp1 protein abundance does not significantly change early after infection in AMs but does in BMDMs; moreover, early after infection, Tax1bp1-deficiency reduced necrotic-like cell death -- an outcome that favors <i>Mtb</i> replication -- in AMs but not BMDMs. …”
  5. 19945

    Map showing the intervention and control LGAs. by Chinwe C. Eze (8787503)

    Published 2025
    “…However, post-intervention, the adjusted mean SARI Stigma Score significantly decreased in the intervention group compared to the control group, with an adjusted mean difference of 37.72 (95% CI: 36.01–39.43, p < 0.000).…”
  6. 19946

    Consort diagram. by Chinwe C. Eze (8787503)

    Published 2025
    “…However, post-intervention, the adjusted mean SARI Stigma Score significantly decreased in the intervention group compared to the control group, with an adjusted mean difference of 37.72 (95% CI: 36.01–39.43, p < 0.000).…”
  7. 19947

    <i>In vitro</i> and <i>in vivo</i> Bioactivity of Stomoxyn. by Erick O. Awuoche (4603582)

    Published 2025
    “…</b> Gene-silencing validation: The relative expression of <i>stomoxyn</i> was measured from dsGFP and dsStomoxyn<i>-</i>treated <i>Gff</i> flies, showing a significant decrease in expression (<i>p</i><0.0001) in the case of dsStomoxyn<i>-</i>treated group. …”
  8. 19948

    Enterocolitis severity increases with DSS concentration. by Cuilee Sha (4836888)

    Published 2025
    “…<b>(D)</b> Cellular proliferation, as measured by number of Ki67-<i>p</i>ositive cells within small intestinal crypts, decreased significantly in 2% DSS. One-way ANOVA with Tukey’s post-hoc, p < 0.0001 (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0323626#pone.0323626.s018" target="_blank">S10</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0323626#pone.0323626.s019" target="_blank">S11 Tables</a>). …”
  9. 19949

    Evaluation of the bactericidal effect of far UV-C irradiation for the peritonitis rat model in the hyper-acute phase. by Kosuke Sugiyama (10042051)

    Published 2024
    “…The bacterial concentration and serum IL-1β and IL-6 levels significantly decreased in the irradiated peritonitis group (**<i>p</i> < 0.01, Student’s <i>t</i>-test). …”
  10. 19950
  11. 19951
  12. 19952

    Flow chart of sequencing data comparison. by Yingping Tian (20961185)

    Published 2025
    “…In addition, interference with <i>COL1A1</i> significantly inhibited the expression of <i>PLTP</i>, <i>ABHD6</i>, <i>LPIN1</i>, and <i>PTGS2</i> and decreased the levels of triglycerides and cholesterol at 4 and 8 days. …”
  13. 19953

    Gene ontology (GO) term for DEGs. by Yingping Tian (20961185)

    Published 2025
    “…In addition, interference with <i>COL1A1</i> significantly inhibited the expression of <i>PLTP</i>, <i>ABHD6</i>, <i>LPIN1</i>, and <i>PTGS2</i> and decreased the levels of triglycerides and cholesterol at 4 and 8 days. …”
  14. 19954

    Data. by Bo Chen (32294)

    Published 2025
    “…</p><p>Results</p><p>Compared to age-/sex-matched controls, diabetic patients exhibited significantly elevated metabolic-inflammatory markers (BMI, LDL-C, CysC, hs-CRP, HOMA-IR; all P < 0.01) and 60% higher baseline urinary 11dhTxB2 levels (2,324.58 vs. 1,452.51 pg/mg creatinine; P = 0.001), with persistent post-ASA disparity (1,205.31 vs. 1,058.02 pg/mg creatinine; P = 0.007). …”
  15. 19955

    Qualitative changes in the implant subgroup. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  16. 19956

    Results of the colorimetric MTT test. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  17. 19957

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  18. 19958

    IOP fluctuation. by Adela Klezlova (22608008)

    Published 2025
    “…In the study group, the IOP was statistically significantly lower by 29% at the end of the follow-up compared to the preoperative measurements (<i><i>p</i></i> = 0.009). …”
  19. 19959

    Minimal data set. by Chamnan Yibcharoenporn (20469017)

    Published 2024
    “…Interestingly, nornidulin suppressed the increase in intracellular cAMP levels caused by forskolin, an activator of adenylate cyclases, in T84 cells. …”
  20. 19960

    Chemical structure of nornidulin. by Chamnan Yibcharoenporn (20469017)

    Published 2024
    “…Interestingly, nornidulin suppressed the increase in intracellular cAMP levels caused by forskolin, an activator of adenylate cyclases, in T84 cells. …”